San Antonio, TX
Some studies suggest that the addition of GIP in tirzepatide provides a more comprehensive approach to regulating hunger and fat storage
A doctor may not prescribe Mounjaro if you or a family member has had a history of certain thyroid diseases
Gallbladder complications GLP-1 receptor agonists are associated with a slightly increased risk of gallbladder disease, including gallstones and cholecystitis
"And remember these are associations, not causations, so it's not to say that GLP-1 use causes NAION or worsening retinopathy, but their use is associated with these conditions." "From an ophthalmologic standpoint, these findings underscore the importance of baseline and follow-up eye examinations for patients starting GLP-1 therapy, especially those with pre-existing retinal or optic nerve risk factors." The expert added that while the benefits of GLP-1 medications in reducing cardiovascular and metabolic risks are "substantial," patients should be counseled on potential visual side effects, and "any sudden visual symptoms should prompt immediate ophthalmic referral." For more Health articles, visit www.foxnews.com/health Novo Nordisk, maker of Ozempic and Wegovy, provided the following statement when contacted by Fox News Digital
"Update on FDA's ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity"
